First Affirmative Financial Network’s AstraZeneca AZN Stock Holding History

First Affirmative Financial Network’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.47M	Buy	+7,477	New	+$1.44M	0.57%	31
2025 Q3	$973K	Buy	6,343 +591	+10%	+$89.4K	0.46%	40
2025 Q2	$804K	Buy	5,752 +880	+18%	+$123K	0.41%	50
2025 Q1	$716K	Buy	4,872 +225	+5%	+$32.6K	0.44%	53
2024 Q4	$609K	Buy	4,647 +839	+22%	+$117K	0.35%	70
2024 Q3	$593K	Buy	3,808 +1,062	+39%	+$171K	0.32%	80
2024 Q2	$428K	Buy	2,746 +427	+18%	+$64.3K	0.3%	102
2024 Q1	$314K	Sell	2,319 -151	-6%	-$20K	0.23%	145
2023 Q4	$333K	Sell	2,470 -278	-10%	-$36.1K	0.27%	126
2023 Q3	$372K	Buy	2,748 +78	+3%	+$10.7K	0.36%	78
2023 Q2	$382K	Sell	2,670 -30	-1%	-$4.41K	0.38%	82
2023 Q1	$375K	Buy	2,700 +92	+4%	+$12.4K	0.43%	72
2022 Q4	$354K	Buy	2,608 +553	+27%	+$69.3K	0.43%	70
2022 Q3	$225K	Buy	2,055 +518	+34%	+$65.7K	0.29%	107
2022 Q2	$203K	Buy	+1,537	New	+$202K	0.23%	131

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

First Affirmative Financial Network's AZN Position: Q1 2026 in Review

First Affirmative Financial Network opened a new position in AstraZeneca (AZN) in Q1 2026: 7,477 shares worth $1.47M. The stake represents 0.57% of the portfolio and ranks #31 among its holdings. This is a return to the name: First Affirmative Financial Network previously reported a position in AZN as recently as Q3 2025.

First Affirmative Financial Network first reported a position in AZN in Q2 2022 and has held it in 15 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

First Affirmative Financial Network held 7,477 shares of AstraZeneca worth $1.47M as of Q1 2026.
AstraZeneca was a new First Affirmative Financial Network position in Q1 2026.
AstraZeneca made up 0.57% of First Affirmative Financial Network's portfolio in Q1 2026, its #31 holding.
First Affirmative Financial Network first reported a position in AstraZeneca in Q2 2022 and has held it in 15 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on First Affirmative Financial Network's 13F filing for Q1 2026, filed 8 May 2026.